about
Evaluation of clonal origin of malignant mesotheliomaNovel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugsHigh incidence of somatic BAP1 alterations in sporadic malignant mesotheliomaGlycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulationHigh-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesotheliomaCombined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700sBAP1 hereditary cancer predisposition syndrome: a case report and review of literatureHigh-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical models
P50
Q21146661-AB0F3F80-F1C4-4195-9335-5327CC9D48D8Q21245491-0E70EF39-36D9-4942-B5CA-681F5B7CD5D5Q24170431-DAD44FD3-F927-4590-87B7-82088308459DQ24655658-530BA9B9-520C-44E2-883D-2115BC7CF8C3Q28395181-10703E54-0D3A-4E0C-87AA-DFBBE9D7929FQ28396964-958BEAA3-F494-4A19-8E25-A597EAB58462Q28397624-E5F98AA3-880A-466B-9A1C-50D3A38EEA05Q28486219-EAD9832B-336E-460F-AA22-6A2D5017C16F
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sandra Pastorino
@ast
Sandra Pastorino
@en
Sandra Pastorino
@es
Sandra Pastorino
@nl
Sandra Pastorino
@sl
type
label
Sandra Pastorino
@ast
Sandra Pastorino
@en
Sandra Pastorino
@es
Sandra Pastorino
@nl
Sandra Pastorino
@sl
prefLabel
Sandra Pastorino
@ast
Sandra Pastorino
@en
Sandra Pastorino
@es
Sandra Pastorino
@nl
Sandra Pastorino
@sl